Skip to Content Facebook Feature Image

Osstem Implant, Exhibits cutting edge Digital Dentistry full lineup at the FAMDENT Show Mumbai 2025

Business

Osstem Implant, Exhibits cutting edge Digital Dentistry full lineup at the FAMDENT Show Mumbai 2025
Business

Business

Osstem Implant, Exhibits cutting edge Digital Dentistry full lineup at the FAMDENT Show Mumbai 2025

2025-06-13 11:30 Last Updated At:11:45

  • Expectations Up for MEDIT Oral Scanner, CBCT
  • Special offers such as free gifts and discounts on products
  • SEOUL, South Korea, June 12, 2025 /PRNewswire/ -- Osstem Implant will participate in the FAMDENT Show Mumbai at the Bombay Exhibition Center in Mumbai, India, from June 20 to 22 next month. At this exhibition, Osstem will hold a special promotion along with a booth exhibition for various digital dentistry lineups.

    The FAMDENT Show Mumbai is one of the most popular dental exhibitions in India, where dental brands and suppliers showcase and demonstrate new products every June. You can check out the latest trends in the global dental industry, and it has established itself as a platform for dentists and dental industry officials to purchase excellent dental products. Participants of the exhibition are given 18 points of continuing dental education (CDE) certified by the Maharashtra State Dental Council (MSDC), which attracts many Indian dentists every year. This year, more than 200 companies and 10,000 dentists and officials are expected to participate in this show.

    In this FAMDENT Show, Dr. Milind Karmarkar, the main performer, 20 other performers will play at the Scientific Conference. Among them, Dr. Vipin Mahurkar, a performer of Osstem, plans to give a lecture under the theme "Digital Dentistry – A revolution toads simplicity and acuity," which is expected to attract enthusiastic responses from participants interested in digital dentistry.

    Osstem will display CBCT T2 and MEDIT Oral Scanner, representative digital dentistry products, at the FAMDENT. CBCT T2 has significantly improved the resolution from 0.2mm Voxel to 0.8mm Voxel, and provides an image size (FOV: Field of View) of up to 15*15cm to diagnose not only the entire oral cavity but also specific areas such as maxillary sinuses and temporomandibular joints. This product is already very popular in the premium CBCT market.

    The MEDIT oral scanner "Medit i900," which will be introduced by Osstem at the exhibition, is intuitively easy to operate with the Touch Band and the Touch Pad, and the weight of the product is reduced to 165 grams, so it is designed to prevent wrist and shoulder strain even when used for a long time, increasing convenience. In addition, its own technology, "dual camera scan" algorithm, has been applied to maximize accuracy.

    Not only the oral scanner, but also the unit-chair K5 and the portable X-ray N1 will be displayed together. K5 and N1 are products that have won the top three global design competitions, and are receiving favorable reviews for their excellent performance and aesthetic appearance.

    Osstem offers special benefits to exhibitors at the exhibitions. Participants can buy Osstem products at a lower price when they purchase them at the exhibition site. They can also sign up for "Denall," an Ostem dental shopping mall, and receive A-Oss (bone graft material) or Hysil (impression material) products for free when they purchase the first product.

    Meanwhile, Osstem signed an exclusive sales and supply contract with Medit, a global oral scanner company, in May for Medit oral scanner products (excluding wireless products) in India. "We will strive to provide better value to customers based on partnerships with global companies with excellent product power," an official at Osstem India said. "We will strive to revitalize digital dentistry in the Indian dental market."

    Photo - https://mma.prnasia.com/media2/2704133/Osstem_Implant_June_2025_India.jpg?p=medium600

SEOUL, South Korea, June 12, 2025 /PRNewswire/ -- Osstem Implant will participate in the FAMDENT Show Mumbai at the Bombay Exhibition Center in Mumbai, India, from June 20 to 22 next month. At this exhibition, Osstem will hold a special promotion along with a booth exhibition for various digital dentistry lineups.

The FAMDENT Show Mumbai is one of the most popular dental exhibitions in India, where dental brands and suppliers showcase and demonstrate new products every June. You can check out the latest trends in the global dental industry, and it has established itself as a platform for dentists and dental industry officials to purchase excellent dental products. Participants of the exhibition are given 18 points of continuing dental education (CDE) certified by the Maharashtra State Dental Council (MSDC), which attracts many Indian dentists every year. This year, more than 200 companies and 10,000 dentists and officials are expected to participate in this show.

In this FAMDENT Show, Dr. Milind Karmarkar, the main performer, 20 other performers will play at the Scientific Conference. Among them, Dr. Vipin Mahurkar, a performer of Osstem, plans to give a lecture under the theme "Digital Dentistry – A revolution toads simplicity and acuity," which is expected to attract enthusiastic responses from participants interested in digital dentistry.

Osstem will display CBCT T2 and MEDIT Oral Scanner, representative digital dentistry products, at the FAMDENT. CBCT T2 has significantly improved the resolution from 0.2mm Voxel to 0.8mm Voxel, and provides an image size (FOV: Field of View) of up to 15*15cm to diagnose not only the entire oral cavity but also specific areas such as maxillary sinuses and temporomandibular joints. This product is already very popular in the premium CBCT market.

The MEDIT oral scanner "Medit i900," which will be introduced by Osstem at the exhibition, is intuitively easy to operate with the Touch Band and the Touch Pad, and the weight of the product is reduced to 165 grams, so it is designed to prevent wrist and shoulder strain even when used for a long time, increasing convenience. In addition, its own technology, "dual camera scan" algorithm, has been applied to maximize accuracy.

Not only the oral scanner, but also the unit-chair K5 and the portable X-ray N1 will be displayed together. K5 and N1 are products that have won the top three global design competitions, and are receiving favorable reviews for their excellent performance and aesthetic appearance.

Osstem offers special benefits to exhibitors at the exhibitions. Participants can buy Osstem products at a lower price when they purchase them at the exhibition site. They can also sign up for "Denall," an Ostem dental shopping mall, and receive A-Oss (bone graft material) or Hysil (impression material) products for free when they purchase the first product.

Meanwhile, Osstem signed an exclusive sales and supply contract with Medit, a global oral scanner company, in May for Medit oral scanner products (excluding wireless products) in India. "We will strive to provide better value to customers based on partnerships with global companies with excellent product power," an official at Osstem India said. "We will strive to revitalize digital dentistry in the Indian dental market."

Photo - https://mma.prnasia.com/media2/2704133/Osstem_Implant_June_2025_India.jpg?p=medium600

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Osstem Implant, Exhibits cutting edge Digital Dentistry full lineup at the FAMDENT Show Mumbai 2025

Osstem Implant, Exhibits cutting edge Digital Dentistry full lineup at the FAMDENT Show Mumbai 2025

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles